Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2358-2361, September 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stern, E.
Right arrow Articles by Dixon, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stern, E.
Right arrow Articles by Dixon, W. J.

A Cytological Scale for Cervical Carcinogenesis1

Elizabeth Stern, Alan B. Forsythe, Lee Youkeles and Wilfrid J. Dixon

School of Public Health [E. S.] and Department of Biomathematics, School of Medicine [A. B. F., L. Y., W. J. D.], University of California, Los Angeles, California 90024

We have postulated a gradient of changes in cervical carcinogenesis ranging from preliminary nonspecific cellular modulations and atypias, through dysplasia as a precursor state, with increasing degrees of severity, to the noninvasive and invasive stages of cancer. In this paper we describe contruction and validation of a numerical scale in relation to the proposed order of progression. We present evidence in support of both the ordering of the categories, defined on the basis of cytological criteria, and the calibration and reliability of the scale. The scale provides a quantitative measure for use in studying natural progression in a defined population. The index of cytological progression can also be used as a biological measure in estimating adverse effects, to be correlated with exposure to the suspected causal factor.

1 Supported by National Institute of Child Health and Human Development Grant NO1-HD-3-2731, NIH.

Received 1/14/74. Accepted 5/24/74.




This article has been cited by other articles:


Home page
ScienceHome page
E Stern, A. Forsythe, L Youkeles, and C. Coffelt
Steroid contraceptive use and cervical dysplasia: increased risk of progression
Science, June 24, 1977; 196(4297): 1460 - 1462.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.